BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 227 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,815,250 | -29.1% | 675,000 | 0.0% | 1.21% | -26.9% |
| Q1 2024 | $22,302,000 | +55.2% | 675,000 | +27.8% | 1.66% | +17.5% |
| Q4 2023 | $14,372,160 | +4.8% | 528,000 | -7.4% | 1.41% | -7.0% |
| Q3 2023 | $13,708,500 | -24.7% | 570,000 | 0.0% | 1.52% | -4.7% |
| Q2 2023 | $18,200,100 | +4.3% | 570,000 | 0.0% | 1.59% | +10.6% |
| Q1 2023 | $17,453,400 | +20.6% | 570,000 | +54.1% | 1.44% | +28.3% |
| Q4 2022 | $14,470,700 | -17.9% | 370,000 | 0.0% | 1.12% | -3.2% |
| Q3 2022 | $17,627,000 | +21.4% | 370,000 | -1.3% | 1.16% | -5.6% |
| Q2 2022 | $14,516,000 | -69.1% | 375,000 | -54.2% | 1.23% | -41.7% |
| Q1 2022 | $46,918,000 | -28.1% | 818,820 | 0.0% | 2.10% | +14.4% |
| Q4 2021 | $65,252,000 | -8.4% | 818,820 | 0.0% | 1.84% | +3.7% |
| Q3 2021 | $71,246,000 | -32.4% | 818,820 | 0.0% | 1.77% | -33.7% |
| Q2 2021 | $105,390,000 | +60.8% | 818,820 | 0.0% | 2.68% | +37.0% |
| Q1 2021 | $65,538,000 | +74.5% | 818,820 | +78.0% | 1.95% | +75.4% |
| Q4 2020 | $37,554,000 | – | 460,000 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |